Empresa Vinings Holdings Inc. Other OTC
Acciones
NDYN
US92744A1051
Farmacéuticos
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
David Mehalick
CEO | Chief Executive Officer | 56 | 28/10/22 |
Brian Cogley
DFI | Director of Finance/CFO | 38 | 17/05/23 |
Daniel Yerace
COO | Chief Operating Officer | 41 | 28/10/22 |
Colleen Delaney
CTO | Chief Tech/Sci/R&D Officer | 57 | 30/08/23 |
Christine Sheehy
CMP | Compliance Officer | 57 | 28/10/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 62 | 28/10/22 | |
Director/Board Member | 55 | 28/10/22 | |
Christine Sheehy
CMP | Compliance Officer | 57 | 28/10/22 |
Gene Salkind
BRD | Director/Board Member | 70 | 28/10/22 |
Chris Calise
BRD | Director/Board Member | 51 | 28/10/22 |
David Mehalick
CEO | Chief Executive Officer | 56 | 28/10/22 |
Daniel Yerace
COO | Chief Operating Officer | 41 | 28/10/22 |
Director/Board Member | 56 | 28/10/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 37 118 593 | 25 373 891 ( 68,36 %) | 0 | 68,36 % |
Información de la empresa
Coeptis Therapeutics Holdings, Inc.
105 Bradford Road Suite 420
15090, Wexford
+
http://www.coeptistx.comVaria. 1 de ene. | Capi. | |
---|---|---|
+43,15 % | 749 mil M | |
+39,42 % | 605 mil M | |
-6,69 % | 351 mil M | |
+18,94 % | 328 mil M | |
+7,92 % | 292 mil M | |
+11,92 % | 216 mil M | |
-2,62 % | 214 mil M | |
+0,40 % | 167 mil M | |
+6,85 % | 165 mil M |